Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138931 · ClinicalTrials.gov registry record
Genetics of Cardiovascular and Neuromuscular Disease
A clinical trial of Cardiomyopathy and Arrhythmia, sponsored by University of Chicago.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT00138931 is a study of Cardiomyopathy and Arrhythmia that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 2,000 participants, above the 477-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (319% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00138931, a study of Cardiomyopathy and Arrhythmia, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some of the identical genes, when mutated, produce both cardiomyopathy and muscular dystrophy. We are working to identify genes and gene mutations associated with cardiomyopathy, arrhythmias and muscular dystrophy. We propose to screen these samples for mutations in genes known to be involved in these disorders.
Conditions Studied
Interventions
- PROCEDURE Blood draw (genetic testing)
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 1996-09 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00138931
The ClinicalTrials.gov registry entry for NCT00138931 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 477-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (319% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Blood draw (genetic testing) is the first listed.
NCT00138931 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00138931 about?
NCT00138931 is a clinical study titled "Genetics of Cardiovascular and Neuromuscular Disease". We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some...
What is the current status of trial NCT00138931?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 1996-09. Estimated completion is 2030-01.
What conditions does trial NCT00138931 study?
This clinical trial studies the following conditions: Cardiomyopathy, Arrhythmia, Muscular Dystrophy.
What interventions are being tested in trial NCT00138931?
The interventions under investigation include: Blood draw (genetic testing) (PROCEDURE).
Who is sponsoring clinical trial NCT00138931?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00138931 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
RECRUITING · Phase 4
-
Molecular Imaging of Primary Amyloid Cardiomyopathy
RECRUITING · NA
-
Impella Reverse Remodeling in End-Stage Heart Failure
RECRUITING
-
Clinical Course Of Disease In Participants With FA-CM
RECRUITING
-
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.